Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (BORAY : OTC)
 
 • Company Description   
Bora Pharmaceuticals Co., Ltd. is a pharmaceutical services company. Bora Pharmaceuticals Co., Ltd. is based in MISSISSAUGA, Ontario.

Number of Employees: 2,100

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.45 Daily Weekly Monthly
20 Day Moving Average: 361 shares
Shares Outstanding: 639.11 (millions)
Market Capitalization: $1,565.82 (millions)
Beta:
52 Week High: $7.00
52 Week Low: $2.21
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.58% -10.63%
12 Week -5.41% -7.21%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
6F. NO. 2 ALY. 36 LN. 26 RUIGUANG RD.
-
Taipei City,F5 114
TWN		 ph: 886-2-2790-1555
fax: -		 public01@bora-corp.com http://www.bora-corp.com
 
 • General Corporate Information   
Officers
Sheng Pao-Shi - Chief Executive and Chairman
Wang Chin-Chu - Director
Chen Kuan-Pai - Director
Yao Leroy - Director
Lai Ming-Jung - Director

Peer Information
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (CHCR)
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (ESRX)
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (MYDP)
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (COR)
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (GBCS)
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 09952D100
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/12/26
Share - Related Items
Shares Outstanding: 639.11
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $1,565.82 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 1.42%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.03
Current Fiscal Year EPS Consensus Estimate: $0.16 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 07/31/2026 - $0.03
Next EPS Report Date: 11/12/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 15.31
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 2.49
EPS Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: 17.77%
vs. Previous Quarter: 47.27%
ROE
09/30/26 - -
06/30/26 - 12.13
03/31/26 - 11.58
ROA
09/30/26 - -
06/30/26 - 4.51
03/31/26 - 4.20
Current Ratio
09/30/26 - -
06/30/26 - -
03/31/26 - 1.38
Quick Ratio
09/30/26 - -
06/30/26 - -
03/31/26 - 1.12
Operating Margin
09/30/26 - -
06/30/26 - 10.36
03/31/26 - 9.96
Net Margin
09/30/26 - -
06/30/26 - 8.42
03/31/26 - 9.01
Pre-Tax Margin
09/30/26 - -
06/30/26 - -
03/31/26 - 14.10
Book Value
09/30/26 - -
06/30/26 - -
03/31/26 - -
Inventory Turnover
09/30/26 - -
06/30/26 - -
03/31/26 - 3.28
Debt-to-Equity
09/30/26 - -
06/30/26 - -
03/31/26 - 0.74
Debt-to-Capital
09/30/26 - -
06/30/26 - -
03/31/26 - 42.56
 

Powered by Zacks Investment Research ©